Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting

PURPOSE: Trauma is a leading cause of mortality, with major bleeding and trauma-induced coagulopathy (TIC) contributing to negative patient outcomes. Treatments for TIC include tranexamic acid (TXA), fresh frozen plasma (FFP), and coagulation factor concentrates (CFCs, e.g. prothrombin complex conce...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Trauma Emerg Surg
Main Authors: Černý, Vladimir, Maegele, Marc, Agostini, Vanessa, Fries, Dietmar, Leal-Noval, Santiago R., Nardai, Gábor, Nardi, Giuseppe, Östlund, Anders, Schöchl, Herbert
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2021
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7782571/
https://ncbi.nlm.nih.gov/pubmed/33399876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00068-020-01563-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares